Cargando…
Effect of Doxorubicin/Pluronic SP1049C on Tumorigenicity, Aggressiveness, DNA Methylation and Stem Cell Markers in Murine Leukemia
PURPOSE: Pluronic block copolymers are potent sensitizers of multidrug resistant cancers. SP1049C, a Pluronic-based micellar formulation of doxorubicin (Dox) has completed Phase II clinical trial and demonstrated safety and efficacy in patients with advanced adenocarcinoma of the esophagus and gastr...
Autores principales: | Alakhova, Daria Y., Zhao, Yi, Li, Shu, Kabanov, Alexander V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747131/ https://www.ncbi.nlm.nih.gov/pubmed/23977261 http://dx.doi.org/10.1371/journal.pone.0072238 |
Ejemplares similares
-
Pluronics and MDR Reversal: An Update
por: Alakhova, Daria Y., et al.
Publicado: (2014) -
Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer
por: Danson, S, et al.
Publicado: (2004) -
Differentiation of human stem cells is promoted by amphiphilic pluronic block copolymers
por: Doğan, Ayşegül, et al.
Publicado: (2012) -
Synthesis of Well-Defined Gold Nanoparticles Using Pluronic: The Role of Radicals and Surfactants in Nanoparticles Formation
por: Sokolsky-Papkov, Marina, et al.
Publicado: (2019) -
Complete Sequence and Annotation of the Mycoplasma phocicerebrale Strain 1049(T) Genome
por: Frasca, Salvatore, et al.
Publicado: (2019)